Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.2009.1549
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Risk of Fetal Death After Treatment With Antipsychotic Medications During Pregnancy

PLoS ONE
Multidisciplinary
2015English

Antihyperglycemic Medications: A Claims-Based Estimate of First-Line Therapy Use Before Initialization of Second-Line Medications

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

The Neural Effects of Psychotropic Medications in Children and Adolescents

Child and Adolescent Psychiatric Clinics of North America
PsychiatryChild HealthMental HealthPediatricsPerinatology
2012English

Second-Generation Antipsychotic Agents in the Treatment of Acute Mania

Archives of General Psychiatry
2007English

Biofuels of First and Second Generation

Journal of KONES. Powertrain and Transport
2016English

Epidemiologic and Clinical Perspectives on Antipsychotic Treatment of Children and Adolescents

Canadian Journal of Psychiatry
PsychiatryMental Health
2012English

The Use of Asthma Controller Medications During Pregnancy and the Risk of Gestational Diabetes

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Use of Mirtazapine in Children and Adolescents

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2018English

Atypical Antipsychotic Use in Treating Adolescents and Young Adults With Developmental Disabilities

Canadian Journal of Psychiatry
PsychiatryMental Health
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy